mRNA-1273 Induces Stronger Response Than BNT162b2 for Immunosuppressed
For immunosuppressed patients, mRNA-1273 induces a stronger seroresponse than BNT162b2, according to a research letter published online.
For immunosuppressed patients, mRNA-1273 induces a stronger seroresponse than BNT162b2, according to a research letter published online.
Researchers compared the antibody response in human milk among women who received COVID-19 mRNA-based vaccines vs vector-based vaccines.
Two 50-µg doses of the mRNA-1273 vaccine are safe and effective for children aged 6 to 11 years, according to a study published online.
Researchers surveyed older adults to determine the frequency and severity of adverse events following receipt of a COVID-19 vaccine booster dose.
The U.S. Food and Drug Administration on Thursday greatly restricted the recommended use of the Johnson & Johnson COVID-19 vaccine.
The incidence of Guillain-Barré syndrome is increased after Ad.26.COV2.S vaccination, but incidence is not increased after mRNA vaccination.
Pfizer Inc. announced Tuesday that it has asked the U.S. FDA to approve emergency use of its booster shot for children ages 5 to 11 years.
The risk for myocarditis and pericarditis after COVID-19 mRNA vaccines is highest in young men after the second vaccine dose.
Researchers assessed the relationship between current CD4 T-cell counts and Immunogenicity after COVID-19 vaccination among people with HIV infection.
Among orthotopic heart transplant recipients, COVID-19 vaccination is associated with fewer COVID-19 infections, hospitalizations, and deaths and no heart transplant-specific adverse events.